{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:54:00Z","timestamp":1770886440693,"version":"3.50.1"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T00:00:00Z","timestamp":1543363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>With recent advances in antiviral therapy, there is an opportunity to eliminate hepatitis C virus (HCV) from the UK population. HCV is common in incarcerated individuals, with previous estimates suggesting ~7% of the UK prison population is anti\u2010HCV antibody positive. Increasing diagnosis and treatment of HCV in prison is a priority in seeking to eliminate transmission in the general population. Thus the study aimed to assess the impact implementation of: (a) A universal offer of blood borne virus testing (UOBBVT) using dry blood spot testing for prisoners at reception to increase diagnosis; (b) Telemedicine clinics (TC) within North East England (NEE) prisons to increase HCV treatment rates. UOBBVT was initially implemented at Her Majesty's Prison (HMP) Durham, commencing March 2016. From March 2016 to February 2017, 2831 of 4280 (66%) new receptions were offered blood borne virus (BBV) testing. Of these, 1495 (53% of offered) accepted BBV testing, of whom 95 (6.4%) were HCV antibody positive, with 47 of those 95 (49.5%) HCV RNA positive, suggesting a prevalence of active infection in the tested population of 3.1% (95% CI 2.4%\u20104.2%). Between August 2015 and October 2017, 80 individuals were seen in the TC and 57 (71%) commenced antiviral therapy. Of those with known outcome (n\u00a0=\u00a029), 100% achieved sustained virological response. In the year prior to implementation, only four patients received HCV treatment. In conclusion, a universal offer of BBV testing to inmates presenting at HMP reception coupled with linkage into specialist care via TC can substantially increase rates of testing, diagnosis and treatment of HCV in this high\u2010prevalence population.<\/jats:p>","DOI":"10.1111\/jvh.13017","type":"journal-article","created":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T11:42:56Z","timestamp":1539430976000},"page":"101-108","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine"],"prefix":"10.1111","volume":"26","author":[{"given":"Sarah","family":"Morey","sequence":"first","affiliation":[{"name":"Viral Hepatitis Service Newcastle upon Tyne Hospitals NHS Foundation Trust Freeman Hospital  Newcastle upon Tyne UK"},{"name":"Northumbria University  Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abi","family":"Hamoodi","sequence":"additional","affiliation":[{"name":"Public Health England  Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dee","family":"Jones","sequence":"additional","affiliation":[{"name":"G4S Health Services  Chelmsford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Young","sequence":"additional","affiliation":[{"name":"Viral Hepatitis Service Newcastle upon Tyne Hospitals NHS Foundation Trust Freeman Hospital  Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Thompson","sequence":"additional","affiliation":[{"name":"G4S Health Services  Chelmsford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Dhuny","sequence":"additional","affiliation":[{"name":"NHS England (Cumbria and the North East)  Darlington UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Buchanan","sequence":"additional","affiliation":[{"name":"Viral Hepatitis Service Newcastle upon Tyne Hospitals NHS Foundation Trust Freeman Hospital  Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Miller","sequence":"additional","affiliation":[{"name":"Viral Hepatitis Service Newcastle upon Tyne Hospitals NHS Foundation Trust Freeman Hospital  Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Hewett","sequence":"additional","affiliation":[{"name":"Viral Hepatitis Service Newcastle upon Tyne Hospitals NHS Foundation Trust Freeman Hospital  Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Valappil","sequence":"additional","affiliation":[{"name":"Viral Hepatitis Service Newcastle upon Tyne Hospitals NHS Foundation Trust Freeman Hospital  Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewan","family":"Hunter","sequence":"additional","affiliation":[{"name":"Department of Infection and Tropical Medicine Newcastle\u2010upon\u2010Tyne Hospitals NHS Foundation Trust Royal Victoria Infirmary  Newcastle\u2010upon\u2010Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5638-2453","authenticated-orcid":false,"given":"Stuart","family":"McPherson","sequence":"additional","affiliation":[{"name":"Viral Hepatitis Service Newcastle upon Tyne Hospitals NHS Foundation Trust Freeman Hospital  Newcastle upon Tyne UK"},{"name":"Institute of Cellular Medicine Newcastle University  Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,11,28]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"Public Health England.Hepatitis C in the UK 2016 report. 2016:1\u201030.https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/565459\/Hepatitis_C_in_the_UK_2016_report.pdf. Accessed February 20 2018."},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-6-170"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02439.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdr011"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-S6-S17"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.001"},{"key":"e_1_2_7_8_1","first-page":"140","volume-title":"Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection","author":"World Health Organization","year":"2016"},{"key":"e_1_2_7_9_1","unstructured":"AASLD.Recommendations for testing managing and treating hepatitis C. Aasld. 2016:1\u201051.http:\/\/hcvguidelines.org\/sites\/default\/files\/HCV-Guidance_July_2016_b.pdf."},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.09.001"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.144878"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27766"},{"key":"e_1_2_7_13_1","first-page":"56","volume-title":"Global Health Sector Strategy on Viral Hepatitis 2016\u20102021","author":"World Health Organization","year":"2016"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62474-5"},{"issue":"4","key":"e_1_2_7_15_1","first-page":"e554","article-title":"Hepatitis C in a prison in the North East of England: what is the economic impact of the universal offer of testing and emergent medications?","volume":"38","author":"Darke J","year":"2016","journal-title":"J Public Health (Oxf)"},{"key":"e_1_2_7_16_1","unstructured":"HMP prison service\u2010north east.https:\/\/www.justice.gov.uk\/contacts\/prison-finder\/North-East."},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12084"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.02.004"},{"key":"e_1_2_7_19_1","unstructured":"Public Health England.Blood\u2010borne virus opt\u2010out testing in prisons: preliminary evaluation of pathfinder programme. Phase 1 April \u2010 September 2014. 2015;(September)."},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis1202"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja13.11062"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckt156"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.13489"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdu022"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2008.01061.x"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00855.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003153"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70216-4"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23407"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i33.7604"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2013-100308"},{"key":"e_1_2_7_32_1","first-page":"124","volume-title":"Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection","author":"World Health Organization","year":"2014"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2773-2"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30075-4"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.13017","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.13017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T01:57:40Z","timestamp":1694656660000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.13017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,28]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1111\/jvh.13017"],"URL":"https:\/\/doi.org\/10.1111\/jvh.13017","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,28]]},"assertion":[{"value":"2018-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}